(Q43801204)

26 November 2017

title

The role of dopamine transporter imaging agent [99mTc]TRODAT-1 in hemi-parkinsonism rat brain (English)

1 reference

26 November 2017

1 reference

Chen YK

1

1 reference

26 November 2017

Liu RS

2

1 reference

26 November 2017

Huang WS

3

1 reference

26 November 2017

Wey SP

4

1 reference

26 November 2017

Ting G

5

1 reference

26 November 2017

Liu JC

6

1 reference

26 November 2017

Shen YY

7

1 reference

26 November 2017

Wan FJ

8

1 reference

26 November 2017

publication date

1 November 2001

1 reference

Nuclear Medicine and Biology

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

923-928

1 reference

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

The effect ofl-DOPA and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

The dopamine transporter: immunochemical characterization and localization in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

The preclinical pharmacologic study of dopamine transporter imaging agent [99mTc]TRODAT-1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Mechanism of 6-hydroxydopamine neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Role of transmitter uptake mechanisms in synaptic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Cloning and expression of a cocaine-sensitive rat dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Dopamine transporter: biochemistry, pharmacology and imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Imaging of dopamine transporters in humans with technetium-99m TRODAT-1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

The molecular cloning and expression of a human synaptic vesicle amine transporter that suppresses MPP+ toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Cell-type-specific expression of catecholamine transporters in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Pharmacology and regulation of the neuronal dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

CNS dopamine autoreceptors: distribution, pharmacology, and function

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopamine into the ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900255-4

7 January 2021

10.1016/S0969-8051(01)00255-4

Identifiers

DOI

1 reference

26 November 2017

1 reference